Charleston, SC -- (SBWIRE) -- 09/11/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Peregrine Pharmaceuticals (NASDAQ:PPHM), Endeavour Silver Corp. (CAN) (NYSE:EXK), Exelixis, Inc. (NASDAQ:EXEL), Ceres Inc (NASDAQ:CERE).
Peregrine Pharmaceuticals (NASDAQ:PPHM) opened its last trade at the price of $1.43. Its closing price was $1.42 after losing -6.58% for the day. The company traded with the total volume of 2,109,659 shares, while its average trading volume remained 1.02 million shares. The beta of this stock stands at 0.98. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer.
Has PPHM Found The Bottom and Ready To Move Up? Find Out Here
Endeavour Silver Corp. (CAN) (NYSE:EXK) percentage change plunged -6.12% to close at $4.60 with the total traded volume of 2,108,966 shares, versus average volume of 1.91 million. The 52 week range of the stock remained $2.88- $10.73, while its day lowest price was $4.55. The share price hit the day highest price of $4.76. Endeavour Silver Corp. engages in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. It produces silver-gold from its underground mines.
Has EXK Found The Bottom And Ready To Gain Momentum? Find Out Here
Exelixis, Inc. (NASDAQ:EXEL) traded on volume of 2,013,484 shares in the last session against average volume of 1.52 million shares. The company started its trading session with the price of $5.60 and closed at $5.59 by scoring +1.73%. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib).
Will EXEL Continue To Move Higher? Find Out Here
Ceres Inc (NASDAQ:CERE) started its last trading session with the price of $1.21and closed at $1.42 by scoring +17.36%. The stock traded with total volume of 2,015,291 shares, while the average trading volume remained 453,425.00 shares. Day range for the stock was $1.21- $1.42. Ceres, Inc., an agricultural biotechnology company, develops and sells energy crops to produce renewable biomass feedstocks in North America. The company energy crops include sweet sorghum that complements sugarcane production.
Why Should Investors Buy CERE After The Recent Gain? Just Go Here and Find Out
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)